Gritstone bio, Inc. (NASDAQ: GRTS) reported Q1 EPS of ($0.34), $0.01 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $1.74 million versus the consensus estimate of $1.16 million.

For earnings history and earnings-related data on Gritstone bio, Inc. (GRTS) click here.